US Stock MarketDetailed Quotes
RNXT RenovoRx
- 1.261
- -0.099-7.30%
Trading Nov 27 11:49 ET
30.26MMarket Cap-2173P/E (TTM)
1.390High1.230Low35.82KVolume1.390Open1.360Pre Close46.22KTurnover0.15%Turnover RatioLossP/E (Static)24.00MShares2.35052wk High4.27P/B29.68MFloat Cap0.53152wk Low--Dividend TTM23.54MShs Float16.740Historical High--Div YieldTTM11.77%Amplitude0.531Historical Low1.290Avg Price1Lot Size
About RenovoRx Company
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Los Altos, CA.
Company Profile
SymbolRNXT
Company NameRenovoRx
Listing DateAug 26, 2021
Issue Price9.00
Founded2012
CEOMr. Shaun R. Bagai
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address4546 El Camino Real,Suite B1
CityLos Altos
ProvinceCalifornia
CountryUnited States of America
Zip Code94022
Phone1-650-284-4433
Websitehttp://www.renovorx.com
Company Executives
- Name
- Position
- Salary
- Shaun R. Bagai
- Chief Executive Officer and Director
- 939.12K
- Leesa Gentry
- Chief Clinical Officer
- --
- Dr. Ramtin Agah, M.D.
- Chief Medical Officer and Chairman of the Board
- 507.76K
- Ronald B. Kocak
- Vice President, Controller and Principal Accounting Officer
- --
- Kirsten Angela Macfarlane
- Independent Director
- 82.00K
- Dr. Laurence J. Marton, M.D.
- Independent Director
- 77.00K
- Dr. Robert J. Spiegel, F.A.C.P.,M.D.
- Independent Director
- 173.72K
- Dr. Una S. Ryan,PhD
- Independent Director
- 82.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
